ABBVAbbVie Inc.
Conviction breakdown
By signal type
By stance
By conviction
By time horizon
The narratives
The presenter discusses AbbVie's growth potential and positive developments in its drug pipeline, indicating a favorable outlook for the stock.
The presenter highlights AbbVie as a stock that is performing well and mentions its potential for solid performance over time, indicating a positive outlook.
AbbVie is discussed positively with expectations of good earnings growth, indicating a favorable outlook.
The presenter presents both the strengths and weaknesses of AbbVie, leading to a neutral stance.
ABBV is mentioned as looking interesting this week, but there is no strong recommendation or clear directional bias provided.
Summaries and classifications are generated automatically by AI and are not reviewed by hand.
Conviction history
1 of 8 days measured · shaded = no mentions
Creator coverage
First in this window: Investor's Business Daily · Oct 7, 2026
| BInvestor's Business Daily185k subs | 3 | 34.62 | BULL | Not stated |
| CZacks Investment Research70k subs | 1 | 16.75 | BULL | 1–6M |
| CGenExDividendInvestor87k subs | 1 | 10.16 | NEUT | Not stated |
Video sources
| 5 Stock Ideas for Your Short ListWatch on YouTube ↗ | Zacks Investment Research | Oct 15, 2026 | 16.75 |
| Stocks Pare Losses As Yields Slash Gains; AbbVie, Apple, Micron In Focus | Stock Market TodayWatch on YouTube ↗ | Investor's Business Daily | Oct 7, 2026 | 15.66 |
| Massive Earnings Week Ahead: Hyperscalers and Megacaps Prepare to ReportWatch on YouTube ↗ | Investor's Business Daily | Oct 23, 2026 | 10.49 |
| My Dividend Portfolio Now Pays Me $480/Day - New All Time Record!Watch on YouTube ↗ | GenExDividendInvestor | Oct 10, 2026 | 10.16 |
| Want a better watchlist? IBD's Mike Webster breaks down his exact weekend stock screening routine.Watch on YouTube ↗ | Investor's Business Daily | Oct 10, 2026 | 8.47 |